This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.


Vincent Ossipow
Partner at Omega Funds


Previously, Vincent worked with Sectoral Asset Management, a healthcare institutional investor, as a Partner for private investments, prior to it he worked at Pictet Bank as a research analyst for biotechnology equities and as a co-manager of the Pictet Biotech Fund. He was before a research fellow at the University of Geneva, studying neuroscience, and trained as a postdoctoral fellow at the National Cancer Institute in Bethesda, MD. He completed a CFA training (CFA Institute), a certificate in International Finance and Global Markets at the Georgetown University School of Business and holds an MS in Computational Sciences, an MS in Molecular Biology, and a PhD in Molecular Biology, all from the University of Geneva. Current board of Directors positions comprise, Immunic (Germany, Nasdaq-listed), Bioinvent (Sweden, Nasdaq OMX-listed), Sophia Genetics (Switzerland, private), Etherna Immuno-Oncology (Belgium, private), Andrew Alliance (Switzerland, private), ForX (Switzerland, private). Prior Board positions comprise, RainDance technologies (US, acquired), LifeSpan (US, acquired), Endosense (Switzerland, acquired), Kuros (Switzerland, public).

Vincent Ossipow's Network

Agenda Sessions

  • Oncology paradigm shifts are for real - Hilton Union Square


Speakers at this event